Drawing for DUET

USPTO serial 90484167

DUET

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DETMER, CAROLYN ROSE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DUET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan M. Kayser

Phi Lan Tinsley K&L GATES LLPONE LINCOLN STREETSTATE STREET FINANCIAL CENTERBOSTON, MA 02111

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic test strips and cartridges for saliva and hormone analysis; Medical diagnostic test strips and cartridges for use in the field of detecting respiratory viruses and other infectious, viral, inflammatory, immunological, autoimmune, and cardiovascular illness; Medical diagnostic reagents and assays for testing of body fluids; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illnessACTIVE—
009Research laboratory analyzers for measuring, testing and analyzing saliva and other bodily fluids; electronic readers for measuring, testing and analyzing saliva and other bodily fluids; cloud connected electronic readers for testing and analyzing saliva and other bodily fluids; Downloadable cloud computing software for storing, transmitting, and analyzing data in the cloud; Portable and handheld digital electronic devices for recording, organizing, transmitting, manipulating, analyzing and reviewing medical data; Computer hardware and recorded software sold as a unit for use with medical patient testing equipment, for receiving, processing, analyzing, transmitting and displaying data; downloadable software application for viewing, transmitting, and analyzing medical data and test results; downloadable software application allowing patients and medical providers to view, transmit, receive, and analyze medical data and test resultsACTIVE—
010Medical diagnostic apparatus for testing infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness; Medical diagnostic apparatus for testing infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness incorporating recorded operating system software; Medical diagnostic apparatus for at-home testing for infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness; Medical diagnostic apparatus for rapid response testing for infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness; Medical diagnostic apparatus for testing infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness incorporating recorded software for analyzing and reporting data to patients and medical providers; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial and hormone testingACTIVE—
042Scientific and technological services, namely, analysis and testing in the field of medical diagnostics; Cloud computing featuring software for use in analyzing and reporting test results in the field of medicine; Providing temporary use of on-line non-downloadable cloud computing software for use in analysis, reporting, and electronic storage of data in the field of medicine; Providing temporary use of non-downloadable cloud-based software for analyzing medical test resultsACTIVE—
044Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness; Medical testing for diagnostic or treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 6, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 6, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 9, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 8, 2024EX5GSOU EXTENSION 5 GRANTED—
May 8, 2024EXT5SOU EXTENSION 5 FILED—
May 8, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 2, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 2, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 2, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 2, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 27, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 24, 2023EX4GSOU EXTENSION 4 GRANTED—
Oct 24, 2023EXT4SOU EXTENSION 4 FILED—
Oct 24, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 4, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 2, 2023EX3GSOU EXTENSION 3 GRANTED—
May 2, 2023EXT3SOU EXTENSION 3 FILED—
May 2, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 4, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 2, 2022EX2GSOU EXTENSION 2 GRANTED—
Nov 2, 2022EXT2SOU EXTENSION 2 FILED—
Nov 2, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 5, 2022EX1GSOU EXTENSION 1 GRANTED—
May 5, 2022EXT1SOU EXTENSION 1 FILED—
May 5, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 30, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 5, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 5, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 15, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 2, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 2, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 2, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 2, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 2, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 1, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2021DOCKASSIGNED TO EXAMINER—
Aug 9, 2021DOCKASSIGNED TO EXAMINER—
Apr 24, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 27, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance